학술논문
Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials
Document Type
Article
Author
Source
In Journal of the American Academy of Dermatology August 2024 91(2):281-289
Subject
Language
ISSN
0190-9622